Growth Hormone Project
Growth Hormone Project
TOPIC:GROWTH HORMONE
6 Causes of acromegaly 7
7 Symptoms of acromegaly 8
8 Test of acromegaly 9
9 Treatment of acromegaly 10
10 Gigantism introduction 11
11 Causes of Gigantism 12
12 Symptoms of Gigantism 13
13 Test of Gigantism 14
14 Treatment of Gigantism 15
15 Dwarfism introduction 16
16 Causes of Dwarfism 17
17 Symptoms of Dwarfism 18
18 Test of Dwarfism 19
19 Treatment of Dwarfism 20
20 Conclusion 21
21 Bibliography 22
GROWTH
HORMONE
:
Growth hormone also
known as
somatotropin or as
human growth
hormone hormone
also known as
somatotropin or as
human growth
hormone [HGH] in its human form, is a peptide hormone that stimulates growth I cell
reproduction and cell regeneration in human development. It is a type of mitogen
which is specific in its human form, is a peptide hormone that stimulates growth I cell
reproduction and cell regeneration in human development. It is a type of mitogen
which is specific only to certain kind of cells. Growth hormone is a 191-amino acid,
Single- chain polypeptide that is synthesized, stored and secreted by somatotropin
cell within the lateral wing of the anterior pituitary gland.
Since the recognition of its multiple and complex effects in the early 1960s, the
physiology and regulation of GH has become a major area of research interest in the
field of endocrinology. In adulthood, its main role is to regulate the metabolism.
Pituitary synthesis and secretion of GH is stimulated by episodic hypothalamic
secretion of GH releasing factor and inhibited by somatostatin. Insulin-like Growth
Factor I (IGF-I) inhibits GH secretion by a negative loop at both hypothalamic and
pituitary levels. In addition, age, gender, pubertal status, food, exercise, fasting,
sleep and body composition play important regulatory roles.
HGH has numerous roles throughout life, from growth itself (including the turnover of
muscle, bone and collagen) to the regulation of particular aspects of metabolic
function, for example increased fat metabolism and the maintenance of a healthier
body composition in later life.HGH is secreted in a pulsatory way, roughly following a
circadian rhythm. Various physiological stimuli can cause HGH secretion, with the
most influential non-pharmacological stimuli being sleep and exercise.
Growth hormone was discovered by Choh Hao Li in the year 1955.He and Herbert
Evan together discovered the GH. Li began to develop methods for isolating the
anterior pituitary hormones in pure form. Li was either the first or among the first to
isolate and identify the anterior pituitary hormones. The initial breakthrough came in
1940 when he isolated luteinizing hormone. ACTH was the first hormone to be
chemically identified and partially synthesized. It took 32 years of research for Li to
synthesize the human growth hormone. The identification, purification and later
synthesis of human growth hormone and the identification of beta-endorphin were his
two most widely recognized achievements. His last accomplishment was the
identification and purification of insulin-like growth factor I.
The efforts to acquire pituitary GH for the treatment of GH-deficient children started in
the mid-1940s. Initial work was on subprimates for nearly a decade. These efforts led
to the purification of bovine GH by Li and Evans at the University of California,
Berkeley, and Fishman at Yale. And porcine GH was purified by Raben and
Westermeyer, at Tufts. But none of these preparations showed a significant
biochemical or metabolic activity because the effects of GH is species specific.
Growth hormone (GH) first was isolated from the human pituitary gland in 1956, by
both Li and Papkoff, in California, and Raben, in Massachusetts, but its biochemical
structure was not elucidated until 1972. In 1958, Raben reported the results of the first
trial to show the effects of human GH on growth. By 1960 it was clear that GH-deficient
children would benefit from pituitary GH. In 1960, National Pituitary Agency (NPA) was
formed to further the goals of coordinating pituitary collection and extraction to support
both basic and clinical research. Between 1963 and 1985 the NPA supervised almost
all of the GH treatment in the United States. And during this period about 7700 children
in the United States and 27,000 children worldwide were given GH extracted from
human pituitary glands to treat severe Growth hormone deficiency (GHD).[3,4]
By 1985, pituitary GH was in use for nearly 30 years in the United States and Canada,
either for research purpose or therapeutically. In 1985, US Food and Drug
Administration (US FDA) received reports of four young adults in the United States
with the fatal, slow viral (prion-mediated) Creuzfeldt Jacob Disease (CJD), who had
been treated with GH from the NPA in the 1960s. The connection was recognized on
reviewing data within a few months by FDA and NIH. On April 19, 1985, distribution of
pituitary GH was suspended and use of human pituitary GH rapidly ceased. And an
exciting and important era in pediatric endocrinology came to an abrupt finish.
The major isoform of the human growth hormone is protein of 191 amino acids and a
molecular weight of 22,124 daltons. The structure includes four helices necessary for
functional interaction with GH receptor. It appear that in structure, GH is evolutionarily
homologous to proclaim and chorionic Somatomammotropin. Despite marked structural
similarities between growth hormone from different species, only human and Old World
monkey growth hormones have significant effects on the human
Several molecular isoforms of GH exist in the pituitary gland and are released to blood. In
particular, a variant of approximately 20 kDa originated by an alternative splicing is present
in a rather constant 1:9 ratio, while recently an additional variant of ~ 23-24 kDa has also
been reported in post-exercise states at higher proportions. This variant has not been
identified, but it has been suggested to coincide with a 22 kDa glycosylated variant of 23 kDa
identified in the pituitary gland. Furthermore, these variants circulate partially bound to a
protein (growth hormone-binding protein, GHBP), which is the truncated part of the growth
hormone receptor, and an acid-labile subunit (ALS).
Growth hormone [GH] has many function :
1. ACROMEGALY:-
Acromegaly is a hormonal disorder that develops when your pituitary gland
produces too much growth hormone during adulthood. When you have too
much growth hormone, your bones increase in size. In childhood, this leads to
increased height and is called gigantism. But in adulthood, a change in height
doesn't occur. Instead, the increase in bone size is limited to the bones of
your hands, feet and face, and is called acromegaly.
Because acromegaly is uncommon and the physical changes occur slowly
over many years, the condition sometimes takes a long time to recognize.
Untreated, high levels of growth hormone can affect other parts of the body, in
addition to your bones. This can lead to serious sometimes even life-
threatening health problems. But treatment can reduce your risk of
complications and significantly improve your symptoms, including the
enlargement of your features. Acromegaly is a rare disorder. Approximately 3
to 14 of every 100,000 people have been diagnosed with this kind of
disorder.
Acromegaly is a rare but serious medical condition that happens when you
have high levels of growth hormone (GH) in your body. Your pituitary
gland normally produces GH, but tumors on your pituitary or in other parts of
your body produce excess GH in acromegaly.
Your pituitary gland is a small, pea-sized endocrine gland located at the base
of your brain below your hypothalamus. Your pituitary gland releases eight
important hormones, including GH.
Growth hormone, also known as human growth hormone (hGH) and
somatotropin, is a natural hormone that acts on many parts of the body to
promote growth in children. Once the growth plates (epiphyses) in your bones
have fused, GH no longer increases height, but your body still needs GH.
After you’ve finished growing, GH helps to maintain normal bone, cartilage
and organ structure and metabolism, including helping to keep your blood
glucose (sugar) levels within a healthy range.
If you have too much GH in your body as an adult, it can result in irregularly-
shaped bones, increased organ size, elevated blood sugar levels
(hyperglycemia) and other symptoms.
Acromegaly can develop at any age after puberty, but healthcare providers
most often diagnose it during the fourth and fifth decades of life (middle age).
Acromegaly occurs when the pituitary gland produces too much growth hormone
(GH) over a long period of time.
The pituitary gland is a small gland at the base of your brain, behind the bridge of
your nose. It produces GH and a number of other hormones. GH plays an important
role in managing your physical growth.
When the pituitary gland releases GH into your bloodstream, it triggers your liver to
produce a hormone called insulin-like growth factor-1 (IGF-1) sometimes also
called insulin-like growth factor-I, or IGF-I. IGF-1 is what causes your bones and
other tissues to grow. Too much GH leads to too much IGF-1, which can cause
acromegaly signs, symptoms and complications.
Symptoms tends to vary from person to person but most common symptoms are:
BLOOD TEST:
Excessive amounts of growth hormone (GH) cause the signs and symptoms of
gigantism. Children with gigantism can also develop certain symptoms as their
pituitary tumor applies pressure to their nearby brain and nerve tissues. The main
sign of gigantism is excessive growth. Children with gigantism grow rapidly in height.
Aside from being very tall/large for their age, physical characteristics of gigantism
include:
Surgery is the most common treatment option for gigantism. The goal is to remove or
reduce the size of the pituitary tumor. Since the pituitary tumors that cause gigantism
are often large, children with gigantism may need multiple surgeries to remove the
tumor and effectively regulate GH levels.
3.DWARFISM:-
Dwarfism is short stature that results from a
genetic or medical condition. Stature is the
height of a person in a standing position.
Dwarfism generally is defined as an adult
height of 4 feet, 10 inches (147 cm) or less. The
average adult height among people with
dwarfism is 4 feet, 1 inch (125 cm) for women
and 4 feet, 4 inches (132 cm) for men.
Dwarfism has many different forms. These
conditions can affect different parts of
the musculoskeletal system including the
growth of the arms, legs, abdomen and/or
head. Dwarfism (skeletal dysplasia) is a rare
condition. The most common type of dwarfism
is achondroplasia, which affects 1 in 15,000 to 40,000 people. Many types of
dwarfism are genetic, which means you can inherit the condition from your parents
and other forms occur randomly through DNA changes.
DWARFISM
DISPROPORTIONATE
PROPORTIONATE
TYPES OF
DWARFISM
Achondroplastic Hypochondroplasia
• Familial: If parents and other family members are short, it can be normal for
their child to be short.
• Small for gestational age: Most babies that are born small will catch up with
their growth within the first two to three years of life, but 10% don’t.
Symptoms of disproportionate dwarfism may include:
• Adults typically are about 4 feet tall
• Average-size torso and very short limbs, especially in the upper halves of
arms and legs
• Short fingers
• Prominent forehead
• Short neck, arms, and legs, but average-size hands and feet
Symptoms of proportionate dwarfism include a smaller head, arms, and legs. But all
are in proportion with each other. Organ systems may be smaller too.
• Height lower than the third percentile on standard charts for age
Imaging
technology
Hormone
tests
Genetic tests:-
• .This test could help manage the condition and aid in family planning.
• For example, if your doctor thinks your daughter may have Turner syndrome,
a special lab test may be done that looks at the X chromosomes in blood
cells.
Imaging technology:-
Medication:-
vosoritide, known by the brand name Voxzogo, to improve growth in children who
have the most common type of dwarfism.
Given as a shot, this medicine is for children 5 years of age and older who have
achondroplasia and open growth plates so they can still grow.
Therapy:-
For people with dwarfism due to low levels of growth hormones, treatment with shots
of a synthetic version of the hormone may increase final height.
In most cases, children receive daily shots for several years until they reach a
maximum adult height — often within the average adult range for their families.
Treatment may continue throughout the teen years and early adulthood to achieve
development. Some people may need lifelong therapy.
Growth hormone is essential for growth, but also modulates protein, lipid, and
carbohydrate metabolism. There is clear evidence that GH excess is associated with
reduced survival, and suggestions that GH deficiency may play a vital part in the
increased mortality seen in patients with hypopituitarism. growth hormone also
increases protein synthesis, gene transcription, and the size and mitosis of somatic
cells. It decreases glucose uptake and utilization and promotes differentiation. Use of
recombinant GH to treat such disorder has many known side effect thus not advised
to take until prescription is provided. GH is a complex hormone that plays important
role in growth and metabolism of protein, carbohydrates and fat. Thus GH plays an
important role in human beings.